patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: low of the day 4.50 ..note VOLUME SPIKE AT THIS POINT..heading back
Reply New Message
Prev Message Back To Forum Threaded View Next Message

yes. You make a valid point. The NASDAQ listing is not written in stone. There are many hoops to jump through to qualify. The level of income is a good question.

Manolo

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply